Baricitinib vs Candesartan

Baricitinib vs Candesartan: Overview

This comparison examines the pharmacological differences between Baricitinib and Candesartan.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Candesartan: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Candesartan — 9 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Candesartan — C33H34N6O6.

Molecular Weight: Baricitinib — 371.4170 g/mol; Candesartan — 610.6640 g/mol.

Type: Baricitinib — Small molecule; Candesartan — Small molecule.